{
    "nctId": "NCT05889871",
    "briefTitle": "A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer",
    "officialTitle": "A Randomized, Controlled, Open-label, Phase III Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer Based on SNF Molecular Classification",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "HR+/HER2-breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 916,
    "primaryOutcomeMeasure": "3-year survival without invasive disease (iDFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women aged \u226518 years and \u226470 years;\n2. Histologically confirmed HR+/HER2- invasive breast cancer (defined by immunohistochemical detection of ER \\&gt; 10% positive tumor cells were defined as ER positive, PR \\&gt; 10% positive tumor cells were defined as positive PR, and ER and/or PR were defined as positive HR. HER2 0-1+ or HER2 ++ but negative by FISH test, no amplification, defined as HER2 negative);\n3. Definition of SNF4 subtype: SNF4 subtype confirmed by digital pathology of H\\&E sections;\n4. High-risk early breast cancer, which was pathologically confirmed as HR+/HER2- and SNF4 subtypes; pT2-4N0-3M0;\n5. Complete the adjuvant chemotherapy selected by the doctor;\n6. No more than 16 months from surgery to randomization, and no more than 12 weeks after non-endocrine therapy;\n7. The functions of major organs are basically normal, meeting the following conditions:\n\n   1. The standard of blood routine examination shall meet: HB \u226590 g/L (no blood transfusion within 14 days); ANC \u22651.5\u00d7109 /L; PLT \u226575\u00d7109 /L;\n   2. Biochemical examination shall meet the following standards: TBIL \u22641.5\u00d7ULN (upper limit of normal value); ALT and AST \u22643 x ULN; In case of liver metastasis, ALT and AST\u2264 5\u00d7ULN; Serum Cr \u22641\u00d7ULN, endogenous creatinine clearance \\> 50 ml/min (Cockcroft-Gault formula);\n8. ECOG score 0 or 1;\n9. Fertile female subjects are required to use a medically approved contraceptive for the duration of the study treatment and for at least 3 months after the last use of the study drug; The subjects voluntarily joined the study, signed the informed consent, had good compliance, and cooperated with follow-up.\n\nExclusion Criteria:\n\n1. bilateral breast cancer;\n2. A history of other malignancies, except cured basal cell carcinoma of the skin and carcinoma in situ of the cervix;\n3. transfer of any part;\n4. Pregnant or lactating women, women of childbearing age can not effectively contraceptive;\n5. Patients participating in other clinical trials;\n6. Severe organ dysfunction (heart, lung, liver and kidney); 50% (cardiac hypertrophy); Severe cardiovascular and cerebrovascular disease (e.g., unstable angina, chronic heart failure, myocardial infarction, or cerebrovascular accident) within 6 months before randomization; Diabetics with poor blood sugar control;\n7. Patients with a history of gastrointestinal bleeding or a definite tendency to gastrointestinal bleeding within the past 6 months, such as esophageal varicose veins with bleeding risk, locally active ulcer lesions, stool occult blood \u2265 (++), shall not be included in the group; If fecal occult blood (+), gastroscopy is required;\n8. Abdominal fistula, gastrointestinal perforation, or abdominal abscess in the 28 days before the study;\n9. Urine routine showed urine protein \u2265++ or confirmed 24 hours urine protein quantity \\> 1.0g;\n10. Patients with hypertension who cannot be reduced to the normal range after antihypertensive medication (systolic blood pressure \\> 140mmHg, diastolic blood pressure \\> 90mmHg).\n11. Allergic constitution, or known allergic history of the drug components of the program;\n12. Previous thyroid dysfunction;\n13. Severe or uncontrolled infection;\n14. Those who have a history of psychotropic drug abuse and cannot abstain or have a history of mental disorders; The researchers determined that the patients were not suitable for the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}